Cit SAS

Where the EU money came from

Funding by EU programme. Amounts are Cit SAS's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• SCR&TOXPartner

  Stem Cells for Relevant Efficient Extended and Normalized Toxicology

  FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

  €237ktheir share
• PRATHPartner

  Preclinical study of Recombinant human Anti-C5 for the Treatment of atypical HUS

  FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗

  €387ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Imperial College of Science Technology and MedicineUnited Kingdom · 1 shared project
• Karolinska InstitutetSweden · 1 shared project
• Jrc -Joint Research Centre- European CommissionBelgium · 1 shared project
• Universitaet LeipzigGermany · 1 shared project
• Universitatsklinikum BonnGermany · 1 shared project
• Department of HealthUnited Kingdom · 1 shared project
• Universita Degli Studi di TriesteItaly · 1 shared project
• Inserm Transfert SAFrance · 1 shared project
• Astrazeneca ABSweden · 1 shared project
• Takara Bio Europe ABSweden · 1 shared project
• Health Protection Agency HpaUnited Kingdom · 1 shared project
• Avantea SRLItaly · 1 shared project
• Cellectis SAFrance · 1 shared project
• CXR Biosciences LimitedUnited Kingdom · 1 shared project
• Labcorp Early Development Laboratories LimitedUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• mutation
• pharmaceutical drugs
• proteins
• stem cells
• toxicology
• vascular diseases